A retrospective study assessing the long term cost efficacy and safety of Soilqua with Glimepiride and Metformin in subjects with type 2 diabetes
Latest Information Update: 12 Aug 2021
At a glance
- Drugs Glimepiride (Primary) ; Insulin-glargine/lixisenatide (Primary) ; Metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 12 Aug 2021 New trial record
- 29 Jun 2021 Results presented at the 81st Annual Scientific Sessions of the American Diabetes Association